{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:33:10Z","timestamp":1771533190028,"version":"3.50.1"},"reference-count":65,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Schizophrenia is a disabling psychiatric condition, affecting around 1% of people worldwide. It has been ranked among the ten most disabling conditions globally. Alongside the psychological and social burdens imposed on individuals suffering from this disease, there are also serious complications regarding the physical health of these patients. Pneumonia is a significant cause of death in patients with schizophrenia. This group of patients also has a higher risk of developing pneumonia and all-cause mortality compared to those without schizophrenia, along with an increased overall mortality rate. A retrospective study revealed that advanced age, underweight, smoking, and the use of high-dose atypical antipsychotics increase the risk of pneumonia-related mortality in hospitalized patients. Our study aims to examine differences in factors associated with pneumonia in hospitalized patients with schizophrenia, before and after the COVID-19 pandemic, as well as to identify potential changes in clinical characteristics and outcomes. Materials and Methods: This is an observational, retrospective analysis, based on the review of medical records of psychiatric inpatients diagnosed with schizophrenia according to the DSM-5 criteria. Patients were selected according to the following criteria: both schizophrenia and pneumonia diagnoses, hospitalized in Spitalul Clinic de Psihiatrie si Neurologie Brasov during 1 March 2018\u20131 March 2020, and 1 March 2022\u20131 March 2024, respectively. Results: A total of 27 patients met the inclusion criteria; 13 patients (48%) were in the pre-pandemic group and 14 patients (52%) in the post-pandemic group. Contrary to other reports, our results showed relatively low pneumonia rates in hospitalized schizophrenia patients (1.02% pre-pandemic and 1.63% post-pandemic), and rates were higher in female patients (61.54% pre-pandemic and 71.43% post-pandemic). Post-pandemic, most cases (42.86%) were registered during summer, in a schizophrenia population with mostly urban residence and with lower smoking rates than the pre-pandemic group. Physical restraints were, however, more frequently utilized in the post-pandemic group. Conclusions: Pneumonia risk factors might register a change in the post-pandemic years. Polypharmacy and physical restraints are probably underestimated risk factors for pneumonia in schizophrenia patients, while a multidisciplinary approach and preventive measures might exert a protective role.<\/jats:p>","DOI":"10.3390\/medicina61071251","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:36:58Z","timestamp":1752161818000},"page":"1251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8697-1945","authenticated-orcid":false,"given":"Ana-Aliana","family":"Miron","sequence":"first","affiliation":[{"name":"Facultatea de Medicin\u0103, Universitatea Transilvania din Bra\u0219ov, Bulevardul Eroilor 29, 500036 Bra\u0219ov, Romania"},{"name":"Spitalul Clinic de Psihiatrie \u0219i Neurologie Bra\u0219ov, Str. Prundului No. 7\u20139, 500123 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petru Iulian","family":"Ifteni","sequence":"additional","affiliation":[{"name":"Facultatea de Medicin\u0103, Universitatea Transilvania din Bra\u0219ov, Bulevardul Eroilor 29, 500036 Bra\u0219ov, Romania"},{"name":"Spitalul Clinic de Psihiatrie \u0219i Neurologie Bra\u0219ov, Str. Prundului No. 7\u20139, 500123 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra-Elena","family":"Lungu","sequence":"additional","affiliation":[{"name":"Spitalul Clinic de Psihiatrie \u0219i Neurologie Bra\u0219ov, Str. Prundului No. 7\u20139, 500123 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena-Luiza","family":"Dragomirescu","sequence":"additional","affiliation":[{"name":"Spitalul Clinic de Psihiatrie \u0219i Neurologie Bra\u0219ov, Str. Prundului No. 7\u20139, 500123 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-9304","authenticated-orcid":false,"given":"Lorena","family":"Dima","sequence":"additional","affiliation":[{"name":"Facultatea de Medicin\u0103, Universitatea Transilvania din Bra\u0219ov, Bulevardul Eroilor 29, 500036 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Teodorescu","sequence":"additional","affiliation":[{"name":"Facultatea de Medicin\u0103, Universitatea Transilvania din Bra\u0219ov, Bulevardul Eroilor 29, 500036 Bra\u0219ov, Romania"},{"name":"Spitalul Clinic de Psihiatrie \u0219i Neurologie Bra\u0219ov, Str. Prundului No. 7\u20139, 500123 Bra\u0219ov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","article-title":"The schizophrenia syndrome, circa 2024: What we know and how that informs its nature","volume":"264","author":"Tandon","year":"2024","journal-title":"Schizophr. Res."},{"key":"ref_2","unstructured":"Hany, M., Rehman, B., Rizvi, A., and Chapman, J. (2024). Schizophrenia. StatPearls, StatPearls Publishing."},{"key":"ref_3","first-page":"152","article-title":"Schizophrenia and Physical Comorbidity","volume":"30","year":"2018","journal-title":"Psychiatr. Danub."},{"key":"ref_4","first-page":"248","article-title":"Mortality in people with schizophrenia: A systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Chen, Y.H., Ren, C.Y., and Liao, Y. (2024). Analysis of risk factors for hospital-acquired pneumonia in schizophrenia. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1414332"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.jcp.0000203598.43314.34","article-title":"Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients","volume":"26","author":"Barnett","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/schbul\/sbr202","article-title":"Second-generation antipsychotic medications and risk of pneumonia in schizophrenia","volume":"39","author":"Kuo","year":"2013","journal-title":"Schizophr. Bull."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v66n0205","article-title":"Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists","volume":"66","author":"Goff","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2021.08.022","article-title":"Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls","volume":"237","author":"Suetani","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13094","DOI":"10.1111\/ijcp.13094","article-title":"Very long-term outcome of schizophrenia","volume":"72","author":"Volavka","year":"2018","journal-title":"Int. J. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Emsley, R., Chiliza, B., Asmal, L., and Harvey, B.H. (2013). The nature of relapse in schizophrenia. BMC Psychiatry, 13.","DOI":"10.1186\/1471-244X-13-50"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0019-5545.58304","article-title":"The story of antipsychotics: Past and present","volume":"51","author":"Ramachandraiah","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2045125318781475","article-title":"The acute efficacy of antipsychotics in schizophrenia: A review of recent meta-analyses","volume":"8","author":"Haddad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Weston-Green, K. (2022). Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.903156"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"ref_16","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am. Fam. Phys."},{"key":"ref_17","first-page":"146","article-title":"First-generation antipsychotics use and reduced risk of pneumonia- Clinical implications in SARS-CoV2 treatment: A systematic review and meta-analysis of observational studies","volume":"12","author":"Eby","year":"2022","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/jnp.10.2.216","article-title":"Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson\u2019s disease","volume":"10","author":"Parsa","year":"1998","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00002512-199710050-00005","article-title":"Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment","volume":"10","author":"Young","year":"1997","journal-title":"Drugs Aging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1756285610389656","article-title":"Quetiapine in the treatment of psychosis in Parkinson\u2019s disease","volume":"3","author":"Shotbolt","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jamapsychiatry.2024.1441","article-title":"Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia","volume":"81","author":"Luykx","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Taylor, D.M., Barnes, T.R.E., and Young, A.H. (2021). The Maudsley Prescribing Guidelines in Psychiatry, John Wiley and Sons. [14th ed.].","DOI":"10.1002\/9781119870203"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.55320\/mjz.46.2.112","article-title":"Prophylactic use of trihexyphenidyl (artane) in schizophrenia and psychosis: A critical review of literature to guide for evidence based practice in Zambia","volume":"46","author":"Sheikh","year":"2019","journal-title":"Med. J. Zamb."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2209736","DOI":"10.1080\/07853890.2023.2209736","article-title":"Association between anticholinergic medication uses and the risk of pneumonia in elderly adults: A meta-analysis and systematic review","volume":"55","author":"Wu","year":"2023","journal-title":"Ann. Med."},{"key":"ref_26","unstructured":"Ghossein, N., Kang, M., and Lakhkar, A.D. (2023, May 08). Anticholinergic Medications, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555893\/."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lee, C.Y., Cheng, Y.D., Cheng, W.Y., Tsai, T.H., and Huang, K.H. (2020). The Prevalence of Anticholinergic Drugs and Correlation with Pneumonia in Elderly Patients: A Population-Based Study in Taiwan. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17176260"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jgs.13932","article-title":"Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study","volume":"64","author":"Chatterjee","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1164\/ajrccm.154.5.8912763","article-title":"Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors","volume":"154","author":"Riquelme","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Meyer, R., Skov, K., Dhillon, I.K., Olsson, E., Graudal, N.A., Baandrup, L., and J\u00fcrgens, G. (2022). Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010082"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E519","DOI":"10.1503\/cmaj.160126","article-title":"Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease","volume":"189","author":"Taipale","year":"2017","journal-title":"CMAJ Can. Med. Assoc. J. = J. L\u2019association Medicale Can."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"De Berardis, D., Ventriglio, A., Fornaro, M., Vellante, F., Martinotti, G., Fraticelli, S., and Di Giannantonio, M. (2020). Overcoming the Use of Mechanical Restraints in Psychiatry: A New Challenge in the Everyday Clinical Practice at the Time of COVID-19. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113774"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Aguilera-Serrano, C., Goodman-Casanova, J.M., Bordallo-Arag\u00f3n, A., Garc\u00eda-S\u00e1nchez, J.A., Mayoral-Cleries, F., and Guzm\u00e1n-Parra, J. (2023). Attitudes about Mechanical Restraint Use in Mental Health Hospitalization Services: A Spanish Survey. Healthcare, 11.","DOI":"10.3390\/healthcare11131909"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1001\/archinte.161.19.2378","article-title":"Pneumonia in Long-term Care: A Prospective Case-Control Study of Risk Factors and Impact on Survival","volume":"161","author":"Vergis","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lim, W.S. (2022). Pneumonia\u2014Overview. Encyclopedia of Respiratory Medicine, Academic Press.","DOI":"10.1016\/B978-0-12-801238-3.11636-8"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.5152\/dir.2022.221881","article-title":"COVID-19 pneumonia: Lessons learned, challenges, and preparing for the future","volume":"28","author":"Ufuk","year":"2022","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jointm.2024.02.005","article-title":"Comparative study on the incidence of non-COVID-19 viral pneumonia before and after the COVID-19 pandemic: A retrospective analysis based on respiratory non-COVID viral nucleic acid results","volume":"4","author":"Tan","year":"2024","journal-title":"J. Intensiv. Med."},{"key":"ref_39","first-page":"PA289","article-title":"Bacterial pneumonias: Before and after the COVID-19 pandemic","volume":"58","author":"Sivakumar","year":"2021","journal-title":"Clin. Probl."},{"key":"ref_40","first-page":"698","article-title":"Community-Acquired Pneumonia in Adults: Diagnosis and Management","volume":"94","author":"Kaysin","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Langan, J., Martin, D., Shajahan, P., and Smith, D.J. (2012). Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): Literature review and case series report. BMC Psychiatry, 12.","DOI":"10.1186\/1471-244X-12-214"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yang, M., Li, Q., Wang, C., Li, L., Xu, M., Yan, F., Chen, W., and Wan, Y. (2021). Influencing factors of hospital-acquired pneumonia infection in the middle-aged and elderly patients with schizophrenia. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.746791"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/JCP.0000000000001090","article-title":"Is Antipsychotic Treatment Associated with Risk of Pneumonia in People with Serious Mental Illness? The Roles of Severity of Psychiatric Symptoms and Global Functioning","volume":"39","author":"Chan","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Saqib, K., Qureshi, A.S., and Butt, Z.A. (2023). COVID-19, Mental Health, and Chronic Illnesses: A Syndemic Perspective. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20043262"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5662\/wjm.v12.i4.200","article-title":"COVID-19 disease and autoimmune disorders: A mutual pathway","volume":"12","author":"Saeed","year":"2022","journal-title":"World J. Methodol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291721004591","article-title":"Antipsychotic medication for women with schizophrenia spectrum disorders","volume":"52","author":"Brand","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhao, V., Gong, Y., Thomas, N., and Das, S. (2024). Clozapine and Pneumonia: Synthesizing the Link by Reviewing Existing Reports\u2014A Systematic Review and Meta-Analysis. Medicina, 60.","DOI":"10.3390\/medicina60122016"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Chen, S., Wang, Y., Liang, J., Li, H., Shi, H., Miao, T., Wu, S., Xiao, A., and Ye, J. (2024). Seasonal characteristics of nosocomial infection in a psychiatric hospital in China with different nosocomial prevention and control backgrounds: A retrospective study. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-65368-8"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0447.2006.00768.x","article-title":"The cardiovascular and respiratory health of people with schizophrenia","volume":"113","author":"Filik","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpsychires.2012.12.007","article-title":"The incidence and all-cause mortality of pneumonia in patients with schizophrenia: A nine-year follow-up study","volume":"47","author":"Chou","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/npr2.12034","article-title":"Risk factors for pneumonia in patients with schizophrenia","volume":"38","author":"Haga","year":"2018","journal-title":"Neuropsychopharmacol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2019.11.003","article-title":"Psychiatric inpatients subjected to physical restraint have a higher risk of deep vein thrombosis and aspiration pneumonia","volume":"62","author":"Funayama","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13033-025-00674-w","article-title":"Changes in psychiatric admissions in the first year of COVID-19 in Ontario, Canada","volume":"19","author":"Betini","year":"2025","journal-title":"Int. J. Ment. Health Syst."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Miron, A.A., Petric, P.S., Teodorescu, A., Ifteni, P., Chele, G., and Szalontay, A.S. (2023). Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics-An Observational Study. Brain Sci., 13.","DOI":"10.3390\/brainsci13020173"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2147\/NDT.S325062","article-title":"Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment","volume":"17","author":"Moga","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/schbul\/sbz093","article-title":"Data from the World Health Organization\u2019s Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated with Clozapine Adverse Drug Reactions","volume":"46","author":"Sanz","year":"2020","journal-title":"Schizophr. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and Long-Term Mortality Risk in Patients with Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1\u201312.5 Years","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Schizophr. Bull."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1176\/appi.ajp.20230744","article-title":"High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals with Schizophrenia: A Finnish 25-Year Follow-Up Register Study","volume":"181","author":"Partanen","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chest.2017.07.030","article-title":"The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia: A Nationwide Population-Based Nested Case-Control Study","volume":"153","author":"Chen","year":"2018","journal-title":"Chest"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e068302","DOI":"10.1136\/bmj-2021-068302","article-title":"Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: Systematic review and meta-analysis","volume":"375","author":"Talic","year":"2021","journal-title":"BMJ"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1590\/1516-4446-2020-0010","article-title":"Schizophrenia and COVID-19: Risks and recommendations","volume":"42","author":"Fonseca","year":"2020","journal-title":"Rev. Bras. Psiquiatr."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:56Z","timestamp":1760033276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071251"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071251","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}